Mrs Barbara McClure

Research Associate

Centre for Cancer Biology

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.


I am a mid-career researcher currently appointed as a Research Associate at The Centre for Cancer Biology in the Vascular Biology and Cell Trafficking Laboratory. I have significant experience studying haematological malignancies including genomics, molecular, receptor and cellular biology. I have published 58 peer reviewed articles receiving >1700 citations. In 2019 I was named an AMP Tomorrow Maker. My current research focus is understanding how a biomarker for poor prognosis Multiple Myeloma contributes to disease progression.

Date Position Institution name
2017 - ongoing Affiliate Lecturer University of Adelaide

Date Institution name Country Title
2017 University of Adelaide Australia PhD
1993 Univeristy of Adelaide Australia BSc(Hons)
1992 University of Adelaide Australia BSc

Date Title Institution Country
HDR Supervisor course University of Adelaide Australia

Date Title Institution name Country
2016 Class B & C Radiation Licence Environment Protection Office -

Year Citation
2025 Quinlan, L., Page, E. C., Rehn, J., McClure, B. J., Osborn, M. P., Moore, A. S., . . . Heatley, S. L. (2025). High Expression of NTRK1 in ETV6::RUNX1 Positive Acute Lymphoblastic Leukaemia Drives Factor Independence and Sensitivity to Larotrectinib.. Pediatric Blood and Cancer, 72(11), e31983-1-e31983-7.
DOI
2024 Kan, W. L., McClure, B. J., Hahn, C. N., & Powell, J. A. (2024). The 10th Barossa meeting: cell signalling to cancer medicine. Cell Death and Disease, 15(3, article no. 230), 1-3.
DOI
2024 Eadie, L. N., Lagonik, E., Page, E. C., Schutz, C. E., Heatley, S. L., McClure, B. J., . . . White, D. L. (2024). Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. Blood, 144(9), 1022-1026.
DOI Scopus6 WoS6 Europe PMC6
2024 Yeung, D. T., Eadie, L. N., Rehn, J., Heatley, S. L., McClure, B. J., Page, E. C., . . . White, D. L. (2024). Diagnostic Genomic Analysis is Prognostic in AYA ALL Patients Treated on a MRD-Stratified Pediatric Protocol. Blood Neoplasia, 2(1), 100041.
DOI Scopus1
2023 Thomson, A. J., Rehn, J. A., Heatley, S. L., Eadie, L. N., Page, E. C., Schutz, C., . . . White, D. L. (2023). Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients. Cancers, 15(19), 4731-1-4731-13.
DOI Scopus6 WoS6 Europe PMC6
2023 Myo Min, K. K., Ffrench, C. B., McClure, B. J., Ortiz, M., Dorward, E. L., Samuel, M. S., . . . Bonder, C. S. (2023). Desmoglein-2 as a cancer modulator: friend or foe?. Frontiers in Oncology, 13(1327478), 1327478-1-1327478-15.
DOI Scopus10 WoS11 Europe PMC9
2023 Eadie, L. N., Rehn, J. A., Breen, J., Osborn, M. P., Jessop, S., Downes, C. E. J., . . . White, D. L. (2023). Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A-Rearranged Acute Lymphoblastic Leukemia. Genes, 14(2), 264-1-264-11.
DOI Scopus1 WoS1 Europe PMC1
2022 Yip, K. H., McKenzie, D., Ramshaw, H. S., Chao, J., McClure, B. J., Raquet, E., . . . Tumes, D. J. (2022). Targeting the human βc Receptor inhibits contact dermatitis in a transgenic mouse model. The Journal of Investigative Dermatology, 142(4), 1103-1113.
DOI Scopus6 WoS6 Europe PMC7
2022 Downes, C. E. J., Rehn, J., Heatley, S. L., Yeung, D., McClure, B. J., & White, D. L. (2022). Identification of a novel GOLGA4–JAK2 fusion gene in B-cell acute lymphoblastic leukaemia. British Journal of Haematology, 196(3), 700-705.
DOI Scopus5 WoS5 Europe PMC5
2022 Page, E. C., Heatley, S. L., Eadie, L. N., McClure, B. J., de Bock, C. E., Omari, S., . . . White, D. L. (2022). HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort. Oncogene, 41(6), 797-808.
DOI Scopus18 WoS17 Europe PMC15
2022 McClure, B. J., Pal, M., Heatley, S. L., Rehn, J., Schutz, C., Breen, J., . . . White, D. L. (2022). Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features. British Journal of Haematology, 196(6), 1407-1411.
DOI Scopus9 WoS8 Europe PMC7
2022 Forgione, M. O., McClure, B. J., Page, E. C., Yeung, D. T., Eadie, L. N., & White, D. L. (2022). TP53 loss‑of‑function mutations reduce sensitivity of acute leukaemia to the curaxin CBL0137.. Oncol Rep, 47(5), 1-7.
DOI Scopus2 WoS2 Europe PMC2
2022 Heatley, S. L., Page, E. C., Eadie, L. N., McClure, B. J., Rehn, J., Yeung, D. T., . . . White, D. L. (2022). Case Report: Precision Medicine Target Revealed by In Vitro Modeling of Relapsed, Refractory Acute Lymphoblastic Leukemia From a Child With Neurofibromatosis. Frontiers in Oncology, 12(851572), 851572-1-851572-6.
DOI Scopus3 WoS2 Europe PMC3
2022 Downes, C. E., McClure, B. J., McDougal, D. P., Heatley, S. L., Bruning, J. B., Thomas, D., . . . White, D. L. (2022). JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies. Frontiers in Cell and Developmental Biology, 10(942053), 1-34.
DOI Scopus27 WoS25 Europe PMC22
2022 Rehn, J., Mayoh, C., Heatley, S. L., McClure, B. J., Eadie, L. N., Schutz, C., . . . White, D. L. (2022). Rascall: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL). PLoS Genetics, 18(10), 1-23.
DOI Scopus18 WoS16 Europe PMC19
2021 Heatley, S. L., Asari, K., Schutz, C. E., Leclercq, T. M., McClure, B. J., Eadie, L. N., . . . White, D. L. (2021). In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy. Leukemia and Lymphoma, 62(5), 1157-1166.
DOI Scopus4 WoS3 Europe PMC3
2021 Sutton, R., Pozza, L. D., Khaw, S. L., Fraser, C., Revesz, T., Chamberlain, J., . . . Kotecha, R. S. (2021). Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab. Pediatric Blood and Cancer, 68(5), 1-7.
DOI Scopus20 WoS17 Europe PMC17
2021 Downes, C. E. J., McClure, B. J., Bruning, J. B., Page, E., Breen, J., Rehn, J., . . . White, D. L. (2021). Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia. NPJ Precision Oncology, 5(1), 1-13.
DOI Scopus21 WoS20 Europe PMC16
2020 Forgione, M. O., McClure, B. J., Yeung, D. T., Eadie, L. N., & White, D. L. (2020). MLLT10 rearranged acute leukemia: incidence, prognosis and possible therapeutic strategies. Genes, Chromosomes and Cancer, 59(12), 709-721.
DOI Scopus12 WoS12 Europe PMC10
2020 McClure, B. J., Heatley, S. L., Rehn, J., Breen, J., Sutton, R., Hughes, T. P., . . . White, D. L. (2020). High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse. British Journal of Haematology, 191(2), 301-304.
DOI Scopus4 WoS3 Europe PMC3
2019 Forgione, M. O., McClure, B. J., Eadie, L. N., Yeung, D. T., & White, D. L. (2019). KMT2A rearranged acute lymphoblastic leukaemia: unravelling the genomic complexity and heterogeneity of this high-risk disease. Cancer Letters, 469, 410-418.
DOI Scopus45 WoS41 Europe PMC35
2018 Dhagat, U., Hercus, T. R., Broughton, S. E., Nero, T. L., Cheung Tung Shing, K. S., Barry, E. F., . . . Parker, M. W. (2018). The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities. mAbs, 10(7), 1018-1029.
DOI Scopus11 WoS12 Europe PMC9
2018 McClure, B., Heatley, S., Kok, C., Sadras, T., An, J., Hughes, T., . . . White, D. (2018). Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression. British Journal of Cancer, 118(7), 1000-1004.
DOI Scopus33 WoS29 Europe PMC26
2017 Sadras, T., Heatley, S., Kok, C., McClure, B., Yeung, D., Hughes, T., . . . White, D. (2017). A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH. Cancer Genetics, 216-217, 86-90.
DOI Scopus13 WoS13 Europe PMC13
2017 Sadras, T., Heatley, S., Kok, C., Dang, P., Galbraith, K., McClure, B., . . . White, D. (2017). Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions. Cancer Letters, 408, 92-101.
DOI Scopus19 WoS21 Europe PMC20
2017 Heatley, S. L., Sadras, T., Kok, C. H., Nievergall, E., Quek, K., Dang, P., . . . White, D. L. (2017). High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment. Haematologica, 102(12), e490-e493.
DOI Scopus56 WoS55 Europe PMC52
2016 Broughton, S. E., Hercus, T. R., Nero, T. L., King-Scott, J., Lopez, A. F., Parker, M. W., . . . Gorman, M. A. (2016). Conformational changes in the GM-CSF receptor suggest a molecular mechanism for affinity conversion and receptor signaling. Structure, 24(8), 1271-1281.
DOI Scopus47 WoS45 Europe PMC39
2016 Panousis, C., Dhagat, U., Edwards, K. M., Rayzman, V., Hardy, M. P., Braley, H., . . . Owczarek, C. M. (2016). CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors. mAbs, 8(3), 436-453.
DOI Scopus41 WoS34 Europe PMC31
2014 Broughton, S., Hercus, T., Hardy, M., McClure, B., Nero, T., Dottore, M., . . . Lopez, A. (2014). Dual mechanism of Interleukin-3 receptor blockade by an anti-cancer antibody. Cell Reports, 8(2), 410-419.
DOI Scopus53 WoS47 Europe PMC41
2013 Hercus, T., Barry, E., Dottore, M., McClure, B., Webb, A., Lopez, A., . . . Murphy, J. (2013). High yield production of a soluble human interleukin-3 variant from E. coli with wild-type bioactivity and improved radiolabeling properties. PLoS ONE, 8(8), e74376-e74376-8.
DOI Scopus16 WoS15 Europe PMC13
2013 Ramshaw, H., Xu, X., Jaehne, E., McCarthy, P., Greenberg, Z., Saleh, E., . . . Schwarz, Q. (2013). Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction. Translational Psychiatry, 3(e327), 1-10.
DOI Scopus27 WoS26 Europe PMC24
2009 Powell, J., Thomas, D., Barry, E., Kok, C., McClure, B., Tsykin, A., . . . Guthridge, M. (2009). Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML. Blood, 114(23), 4859-4870.
DOI Scopus53 WoS51 Europe PMC49
2008 Hansen, G., Hercus, T., Mc Clure, B., Stomski, F., Dottore, M., Powell, J., . . . Parker, M. (2008). The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell, 134(3), 496-507.
DOI Scopus272 WoS251 Europe PMC223
2006 Guthridge, M., Powell, J., Barry, E., Stomski, F., Mc Clure, B., Ramshaw, H., . . . Lopez, A. (2006). Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch. EMBO Journal, 25(3), 479-489.
DOI Scopus72 WoS71 Europe PMC69
2004 Guthridge, M., Barry, E., Felquer, F., Mc Clure, B., Stomski, F., Ramshaw, H., & Lopez, A. (2004). The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kB and induction of bcl-2. Blood, 103(3), 820-827.
DOI Scopus67 WoS64 Europe PMC56
2003 Mc Clure, B., Hercus, T., Cambareri, B., Woodcock, J., Bagley, C., Howlett, G., & Lopez, A. (2003). Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex. Blood, 101(4), 1308-1315.
DOI Scopus37 WoS34 Europe PMC30
2001 Mc Clure, B., Stomski, F., Lopez, A., & Woodcock, J. (2001). Perverted responses of the human granulocyte-macrophage colony-stimulating factor receptor in mouse cell lines due to cross-species b-subunit association. Blood, 98(10), 3165-3168.
DOI Scopus6 WoS6 Europe PMC6
2001 Mc Clure, B., Woodcock, J., Harrison-Findik, D., Lopez, A., & D'Andrea, R. (2001). GM-CSF binding to its receptor induces oligomerisation of the common beta-subunit. Cytokine, 13(4), 240-243.
DOI Scopus6 WoS6 Europe PMC4
2001 Ramshaw, H. S., Woodcock, J. M., McClure, B. J., Hercus, T. R., Lopez, A. F., & Bagley, C. J. (2001). New approaches in the treatment of asthma. Immunology and Cell Biology, 79(2), 154-159.
DOI Scopus29 WoS26 Europe PMC20
2000 Guthridge, M., Stomski, F., Barry, E., Winnall, W., Woodcock, J., Mc Clure, B., . . . Lopez, A. (2000). Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Molecular Cell, 6(1), 99-108.
DOI Scopus71 WoS68 Europe PMC62
2000 Rossjohn, J., McKinstry, W., Woodcock, J., Mc Clure, B., Hercus, T., Parker, M., . . . Bagley, C. (2000). Structure of the activation domain of the GM-CSF/IL-3/IL-5 receptor common b-chain bound to an antagonist. Blood, 95(8), 2491-2498.
DOI Scopus51 WoS45 Europe PMC38
2000 Stomski, F. C., Guthridge, M. A., Barry, E. F., Winnall, W., Woodcock, J. M., Lopez, A. F., & Ramshaw, H. (2000). Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. EXPERIMENTAL HEMATOLOGY, 28(7), 119.
DOI
1999 Sun, Q., Jones, K., McClure, B., Cambareri, B., Zacharakis, B., Iversen, P., . . . Lopez, A. (1999). Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulting factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors. Blood, 94(6), 1943-1951.
DOI Scopus61 WoS52 Europe PMC33
1998 Woodcock, J., McClure, B., Zacharakis, B., Slomski, F., & Lopez, A. (1998). Determining the biological significance of the preformed GM-CSF receptor. Experimental Hematology, 26(8), 720.
1997 Woodcock, J., McClure, B., Stomski, F., Baglev, C., & Lopez, A. (1997). The mechanism of GM-CSF receptor activation. Experimental Hematology, 25(8), 760.
1997 Woodcock, J. M., McClure, B. J., Stomski, F. C., Elliott, M. J., Bagley, C. J., & Lopez, A. F. (1997). The human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor exists as a preformed receptor complex that can be activated by GM- CSF, interleukin-3, or interleukin-5. Blood, 90(8), 3005-3017.
DOI Scopus54 WoS53 Europe PMC34
1996 Dyson, P. G., Jackson, K. A., McClure, B. J., Rawling, T. P., & To, L. B. (1996). Increased levels of megakaryocyte progenitors in peripheral blood mobilised by chemotherapy and/or haemopoietic growth factor protocols. Bone Marrow Transplantation, 18(4), 705-712.
Scopus12 WoS11 Europe PMC7

Year Citation
2017 Broughton, S. E., Hercus, T., Nero, T., Dottore, M., McClure, B., Dhagat, U., . . . Parker, M. W. (2017). The GM-CSF Receptor - mechanisms for affinity conversion and signalling. In ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES Vol. 73 (pp. C1279). INT UNION CRYSTALLOGRAPHY.
DOI
2014 Broughton, S. E., Hercus, T., Nero, T., Dottore, M., McClure, B., Dhagat, U., . . . Parker, M. W. (2014). The GM-CSF Receptor - mechanisms for affinity conversion and signalling. In ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES Vol. 70 (pp. C1279). INT UNION CRYSTALLOGRAPHY.
2014 Broughton, S. E., Hercus, T. R., Nero, T. L., Dhagat, U., Dottore, M., McClure, B. J., . . . Parker, M. W. (2014). Structural and functional analysis of the GM-CSF:GM-CSF receptor alpha chain binary complex provide new insights into signalling of the GM-CSF ternary complex. In CYTOKINE Vol. 70 (pp. 32). Melbourne, AUSTRALIA: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD.
DOI
2014 Hercus, T. R., Broughton, S. E., Hardy, M. P., Nero, T. L., McClure, B. J., Dottore, M., . . . Lopez, A. F. (2014). Insights into the function of an anti-leukaemia antibody: structural studies of CSL362 bound to soluble CD123. In CYTOKINE Vol. 70 (pp. 46). Melbourne, AUSTRALIA: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD.
DOI WoS1
2009 Guthridge, M., Thomas, D., Barry, E. F., Chung, K. H., McClure, B. J., To, L. B., . . . Powell, J. A. (2009). Expression Profiling of a Hemopoietic Cell Survival Transcriptome Identifies a Functional Prognostic Gene Signature in Normal Karyotype AML.. In BLOOD Vol. 114 (pp. 647). New Orleans, LA: AMER SOC HEMATOLOGY.
2007 Lopez, A., Hercus, T., Hansen, G., Woodcock, J., McClure, B., Stomski, F., . . . Parker, M. P. (2007). The structure of the GM-CSF receptor ternary complex reveals a new, mode of cytokine receptor activation. In BLOOD Vol. 110 (pp. 35A). Atlanta, GA: AMER SOC HEMATOLOGY.
DOI

Year Citation
2024 Toomes, C., McClure, B., Best, G., Ebert, L., Vandyke, K., Cockshell, M., . . . Bonder, C. (2024). Elevated Desmoglein-2 Surface Expression Is an Independent Predictor of Poor Outcome in Multiple Myeloma. Poster session presented at the meeting of CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. CIG MEDIA GROUP, LP.
2023 Rehn, J., Schutz, C., Page, E., Heatley, S., Eadie, L., McClure, B., . . . White, D. (2023). High expression of DUX4 mRNA is a reliable indicator of DUX4-rearranged acute lymphoblastic leukaemia. Poster session presented at the meeting of Australian and New Zealand Children’s Haematology/Oncology group (ANZCHOG) Scientific Meeting.
2022 Thomson, A., Rehn, J., Heatley, S., Eadie, L., McClure, B., Page, E., . . . White, D. (2022). Benchmarking the detection rate of IGH gene fusions in B-cell Acute Lymphoblastic Leukaemia. Poster session presented at the meeting of Australian Bioinformatics and Computational Biology Society (ABACBS) Conference.
2021 Heatley, S. L., Page, E. C., Eadie, L. N., McClure, B. J., Rehn, J., Yeung, D. T., . . . White, D. L. (2021). Modeling Relapsed, Refractory Acute Lymphoblastic Leukemia from a Child with Neurofibromatosis. Poster session presented at the meeting of BLOOD. GA, Atlanta: AMER SOC HEMATOLOGY.
DOI WoS1
2021 Eadie, L., Heatley, S., McClure, B., Rehn, J., Schutz, C., Breen, J., . . . White, D. (2021). Next Generation Genomic Analyses Inform Druggable Targets In T-All Patients. Poster session presented at the meeting of 4th International T-ALL/T-NHL conference: T-ALL2020: Omics, genetics and therapy.
2021 McClure, B., Heatley, S., Grose, R., & White, D. (2021). Activation of the immune cell repertoire in B-cell acute lymphoblastic leukaemia. Poster session presented at the meeting of 12th Biennial Childhood Leukemia and Lymphoma Symposium (CLLS).
2021 Eadie, L., Heatley, S., McClure, B., Rehn, J., Schutz, C., Breen, J., . . . White, D. (2021). Next Generation Genomic Analyses Inform Druggable Targets In T-All Patients. Poster session presented at the meeting of 12th Biennial Childhood Leukemia and Lymphoma Symposium (CLLS).
2020 Rehn, J. A., Breen, J., Heatley, S. L., McClure, B. J., Eadie, L. N., Schutz, C. E., . . . White, D. L. (2020). Targeted pseudo-alignment technique for rapid and accurate identification of disease-causing variants in acute lymphoblastic leukaemia. Poster session presented at the meeting of 14th Annual Florey Postgraduate Conference. Adelaide, South Australia.
2020 Rehn, J. A., Breen, J., Heatley, S. L., McClure, B. J., Eadie, L. N., Schutz, C. E., . . . White, D. L. (2020). Pseudo-alignment technique for accurate detection of disease-causing variants in acute lymphoblastic leukaemia. Poster session presented at the meeting of Australian Bioinformatics and Computational Biology Society (ABACBS) 2020 National Conference. Canberra, ACT.
2020 Forgione, M. O., McClure, B. J., Eadie, L. N., & White, D. L. (2020). CD44 and its ligand osteopontin are upregulated specifically in KMT2A-AFF1 T-cell acute lymphoblastic leukaemia. Poster session presented at the meeting of ASMR Annual Scientific Meeting. Adelaide, South Australia.
2020 Eadie, L. N., Rehn, J., Heatley, S. L., McClure, B. J., Schutz, C. S., Breen, J., . . . White, D. L. (2020). Next Generation Genomic Analyses in T-ALL Patients Identify Recurrent and Novel Genomic Abnormalities. Poster session presented at the meeting of BLOOD. ELECTR NETWORK: ELSEVIER.
DOI WoS1
2020 Eadie, L., Heatley, S., McClure, B., Schutz, C., Breen, J., Hughes, T., . . . White, D. (2020). Next Generation Genomic Analyses Inform Druggable Targets In T-All Patients. Poster session presented at the meeting of Australian & New Zealand Children’s Haematology/Oncology Group.
2020 McClure, B., Heatley, S., Grose, R., Yeung, D., & White, D. (2020). Activation of the immune cell repertoire in B-cell acute lymphoblastic leukaemia.. Poster session presented at the meeting of Australian & New Zealand Children’s Haematology/Oncology Group.
2020 Downes, C. E. J., McClure, B. J., Rehn, J., Breen, J., Bruning, J. B., Yeung, D. T., & White, D. L. (2020). Acquired Mutations within the JAK2 Kinase Domain Confer Resistance to JAK Inhibitors in an <i>in Vitro</i> model of a High-Risk Acute Lymphoblastic Leukemia. Poster session presented at the meeting of BLOOD. ELECTR NETWORK: ELSEVIER.
DOI WoS2
2019 Eadie, L., Heatley, S. L., McClure, B. J., Rehn, J. A., Breen, J., Hughes, T. P., . . . White, D. L. (2019). Exploration of the Genomic Diversity in T-ALL Patients Using mRNA Sequencing. Poster session presented at the meeting of 1st European Society of Haematology (ESH) Translational Conference on ALL. Berlin, Germany.
2019 Eadie, L., Heatley, S. L., McClure, B. J., Rehn, J. A., Breen, J., Hughes, T. P., . . . White, D. L. (2019). Exploration of the Genomic Diversity in T-ALL Patients Using mRNA Sequencing. Poster session presented at the meeting of ASMR Annual Scientific Meeting. Adelaide, South Australia.
2019 Rehn, J. A., Breen, J., Heatley, S. L., McClure, B. J., Eadie, L., Schutz, C. E., . . . White, D. L. (2019). Investigating “alignment-free” computational techniques for the accurate identification of Acute Lymphoblastic Leukaemia (ALL) gene fusion events. Poster session presented at the meeting of SAHMRI Annual Scientific Meeting. Adelaide, South Australia.
2019 Heatley, S. L., McClure, B. J., Eadie, L. N., Rehn, J. A., Breen, J., Hughes, T. P., . . . White, D. L. (2019). Exploring the genomic diversity of AYA and adult high-risk B-ALL cases by mRNA sequencing. Poster session presented at the meeting of SAHMRI Annual Scientific Meeting. Adelaide, South Australia.
2019 Yeung, D., Greenwood, M., Rehn, J., Heatley, S., McClure, B., Eadie, L., . . . White, D. (2019). High risk genomic alterations identified at the time of diagnosis are strongly associated with MRD and subsequent poor outcomes in AYA ALL patients treated on a pediatric inspired chemotherapy regimen. Poster session presented at the meeting of Blood. Orlando, CA: American Society of Hematology.
DOI
2018 Downes, C., McClure, B., & White, D. L. (2018). Identification of ruxolitinib resistance mutations in Pro-B cells driven by a high-risk B-ALL JAK2-fusion. Poster session presented at the meeting of Poster, Childhood Leukemia and Lymphoma Symposium (CLLS). Helsinki, Finland.
2018 Heatley, S. L., Mayne, B. T., McClure, B. J., Kok, C., Sadras, T., Dang, P., . . . White, D. L. (2018). Exploring the genomic diversity of AYA and adult high-risk B-ALL cases by mRNA sequencing. Poster session presented at the meeting of 23rd Congress of European Hematology Association. Stockholm, Sweden.
2018 Downes, C. E., McClure, B. J., Heatley, S. L., Yeung, D. T., & White, D. L. (2018). Identification of ruxolitinib resistance mutations in Pro-B cells driven by a high-risk B-ALL JAK2-fusion. Poster session presented at the meeting of Poster, New Directions in Leukaemia Research (NDLR).
2018 Heatley, S. L., McClure, B. J., Kok, C., Sadras, T., Dang, P., Galbraith, K., . . . White, D. L. (2018). Exploring the genomic diversity of adult and AYA cases with high-risk B-ALL by mRNA sequencing. Poster session presented at the meeting of NDLR.
2018 Downes, C. E., McClure, B. J., Mayne, B. T., Bruning, J. B., Heatley, S. L., Kok, C., . . . White, D. L. (2018). Identification and computational modelling of ruxolitinib resistant mutations in JAK2-rearranged B-cell acute lymphoblastic leukaemia. Poster session presented at the meeting of Poster, Adelaide Protein Group (APG) Student Awards.
2018 Downes, C. E., McClure, B. J., Mayne, B. T., Bruning, J. B., Heatley, S. L., Kok, C., . . . White, D. L. (2018). Identification of ruxolitinib resistance mutations in Pro-B cells driven by a high-risk JAK2 fusion in B-cell acute lymphoblastic leukaemia. Poster session presented at the meeting of Oral, Australian Society for Medical Research (ASMR) SA Meeting.
2018 Downes, C. E., McClure, B. J., Mayne, B. T., Bruning, J. B., Heatley, S. L., Kok, C., . . . White, D. L. (2018). Identification and Characterisation of Ruxolitinib Resistant Mutations in JAK2-rearranged B-cell Acute Lymphoblastic Leukaemia. Poster session presented at the meeting of Poster, Australasian Genomic Technologies Association (AGTA) Annual Conference.
2018 Downes, C. E., McClure, B. J., Mayne, B. T., Bruning, J. B., Heatley, S. L., Kok, C., . . . White, D. L. (2018). Identification of ruxolitinib resistance mutations in Pro-B cells driven by a high-risk B-ALL JAK2-fusion. Poster session presented at the meeting of Poster, Australian and New Zealand Children's Haematology/Oncology Group (ANZCHOG) Annual Scientific Meeting.
2018 Downes, C. E., McClure, B. J., Mayne, B. T., Bruning, J. B., Heatley, S. L., Kok, C., . . . White, D. L. (2018). Identification and computational modelling of ruxolitinib resistant mutations in JAK2-rearranged B-cell acute lymphoblastic leukaemia. Poster session presented at the meeting of Poster, South Australian Health and Medical Research Institute (SAHMRI) Annual Scientific Meeting.
2018 Downes, C. E., McClure, B. J., Mayne, B. T., Bruning, J. B., Heatley, S. L., Kok, C., . . . White, D. L. (2018). Identification and computational modelling of ruxolitinib resistant mutations in JAK2-rearranged B-cell acute lymphoblastic leukaemia. Poster session presented at the meeting of Poster, European Molecular Biology Laboratory (EMBL) Australia Postgraduate Symposium.
2017 McClure, B. J., Heatley, S. L., Kok, C., Sadras, T., An, J., Quek, K., . . . White, D. L. (2017). EP300-ZNF384 is a recurrent fusion gene with distinct gene expression in adolescent/young adult pre-B-ALL patients. Poster session presented at the meeting of ANZCHOG.
2017 Heatley, S. L., Sadras, T., Kok, C., Nievergall, E., Quek, K., Dang, P., . . . White, D. L. (2017). High Prevalence of Relapse in Australian Children with Ph-like Acute Lymphoblastic Leukemia Despite Risk-Adapted Treatment. Poster session presented at the meeting of ANZCHOG.
2017 McClure, B. J., Heatley, S. L., Sadras, T., Sutton, R., & White, D. L. (2017). EP300-ZNF384 is a recurrent fusion gene with distinct gene expression in adolescent/young adult Australian pre-B-acute lymphoblastic leukaemia. Poster session presented at the meeting of IBFM.
2017 Downes, C. E., McClure, B. M., Heatley, S. H., Sadras, T. S., Hughes, T. H., Kok, C. K., . . . White, D. W. (2017). Identification and cloning of a novel GOLGA4-JAK2 fusion from an adult patient with B-cell Acute Lymphoblastic Leukaemia. Poster session presented at the meeting of Poster, Australian Society for Medical Research (ASMR) SA Meeting. Adelaide.
2016 White, D. L., McClure, B., Heatley, S., Sadras, T., Quek, K., & Hughes, T. (2016). Investigation of the transforming capacity of a recently identified EP300-ZNF384 fusion gene in adult acute lymphoblastic leukaemia. Poster session presented at the meeting of Poster Session. Adelaide, SA.
2016 Galbraith, K., Sadras, T., McClure, B., Heatley, S., & White, D. L. (2016). Identification of novel therapeutic targets in CRLF2 rearranged acute lymphoblastic leukaemia. Poster session presented at the meeting of Poster Session. Adelaide, SA.
2016 Heatley, S., Sadras, T., McClure, B., Kok, C. H., Dang, P., Nievergall, E., . . . White, D. L. (2016). The Incidence of Ph-like Acute Lymphoblastic Leukaemia (ALL) Increases with Age and is Characterised by Poor Outcome. Poster session presented at the meeting of Poster Session. Melbourne, VIC.

Year Citation
2017 Downes, C. E. (2017). Cloning, Signalling Characterisation and JAK2 Inhibitor-Resistance of Two JAK2 Fusions in High-Risk B-ALL. (Undergraduate Dissertation).

Date Role Research Topic Program Degree Type Student Load Student Name
2019 - 2022 Co-Supervisor Characterising KMT2A and MLLT10 Rearranged Acute Lymphoblastic Leukaemia Doctor of Philosophy Doctorate Full Time Miss Michelle Olivia Forgione
2018 - 2022 Co-Supervisor Precision Medicine Approaches for JAK2-Rearranged Acute Lymphoblastic Leukaemia: The Efficacy of Targeted Therapies and Molecular Mechanisms of Drug Resistance Doctor of Philosophy Doctorate Full Time Miss Charlotte Emma-Jeane Toomes

Date Role Research Topic Location Program Supervision Type Student Load Student Name
2022 - 2022 Principal Supervisor Identification of therapeutically targetable pathways in EP300::ZNF384 rearranged B-cell Acute Lymphoblastic Leukaemia SAHMRI / University of Adelaide Adelaide Health and Medical Sciences Honours Full Time Annabelle Dickens
2019 - 2019 Co-Supervisor Characterising the contribution of disease-associated somatic variants in DEAD/H-Box Helicase 11 in B-cell Acute Lymphoblastic Leukemogenesis SAHMRI University of Adelaide, School of Biological Science Honours Full Time Xhin Lin Ngo

Connect With Me

External Profiles

Other Links